Sources | Names Used |
---|---|
CTRPv2 | JQ-1:UNC0638 (2:1 mol/mol) |
PharmacoGx | JQ-1:UNC0638 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPECC1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | POTED | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | RP11-1099M24.7 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | CLASP2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | ATP13A1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TTN | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | HAL | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | NUDT19 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | CHRNA4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | RNASEK-C17orf49 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |